In Silico Drug Discovery and Development is a ground-breaking approach in the pharmaceutical industry, utilizing computational techniques and bioinformatics to expedite drug discovery and significantly reduce costs and time. Researchers employ algorithms and simulations to predict interactions between potential drug compounds and biological targets, identifying promising candidates before costly laboratory testing. This innovative process begins with integrating vast databases containing molecular and biological information. Through virtual screening, computational models identify compounds with the highest likelihood of therapeutic success. Molecular dynamics simulations offer insights into drug behavior at the atomic level, aiding in the design of more effective and safer compounds. In Silico methods are valuable for predicting pharmacokinetics and toxicity, enabling researchers to prioritize candidates with an optimal balance of efficacy and safety. This approach facilitates the understanding of complex biological pathways, allowing for the development of drugs tailored to specific molecular targets. As technology advances and computational power increases, this approach continues to reshape drug development, offering unprecedented opportunities for more efficient, cost-effective, and targeted drug discovery.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation